<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>63(8)</volume><submitter>Aoki T</submitter><pubmed_abstract>Programmed death 1 (PD-1)/programmed death ligand 1 (PD-L1) pathway blockade has become a promising therapeutic target in adult cancers. We evaluated PD-L1 expression and tumor-infiltrating CD8(+) T cells in formalin-fixed, paraffin-embedded tumor specimens from 53 untreated pediatric patients with eight cancer types: neuroblastoma, extracranial malignant germ cell tumor, hepatoblastoma, germinoma, medulloblastoma, renal tumor, rhabdomyosarcoma, and atypical teratoid/rhabdoid tumor. One rhabdomyosarcoma with the shortest survival exhibited membranous PD-L1 expression and germinoma contained abundant tumor-infiltrating CD8(+) T cells and PD-L1-positive macrophages. The PD-1/PD-L1 pathway tended to be inactive in pediatric cancers.</pubmed_abstract><journal>Pediatric blood &amp; cancer</journal><pagination>1461-4</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5074238</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Low Frequency of Programmed Death Ligand 1 Expression in Pediatric Cancers.</pubmed_title><pmcid>PMC5074238</pmcid><pubmed_authors>Hanada R</pubmed_authors><pubmed_authors>Kurihara J</pubmed_authors><pubmed_authors>Kishimoto H</pubmed_authors><pubmed_authors>Kawashima H</pubmed_authors><pubmed_authors>Hino M</pubmed_authors><pubmed_authors>Aoki T</pubmed_authors><pubmed_authors>Koh K</pubmed_authors><pubmed_authors>Motohashi S</pubmed_authors><pubmed_authors>Kyushiki M</pubmed_authors><pubmed_authors>Arakawa Y</pubmed_authors><pubmed_authors>Shimojo N</pubmed_authors></additional><is_claimable>false</is_claimable><name>Low Frequency of Programmed Death Ligand 1 Expression in Pediatric Cancers.</name><description>Programmed death 1 (PD-1)/programmed death ligand 1 (PD-L1) pathway blockade has become a promising therapeutic target in adult cancers. We evaluated PD-L1 expression and tumor-infiltrating CD8(+) T cells in formalin-fixed, paraffin-embedded tumor specimens from 53 untreated pediatric patients with eight cancer types: neuroblastoma, extracranial malignant germ cell tumor, hepatoblastoma, germinoma, medulloblastoma, renal tumor, rhabdomyosarcoma, and atypical teratoid/rhabdoid tumor. One rhabdomyosarcoma with the shortest survival exhibited membranous PD-L1 expression and germinoma contained abundant tumor-infiltrating CD8(+) T cells and PD-L1-positive macrophages. The PD-1/PD-L1 pathway tended to be inactive in pediatric cancers.</description><dates><release>2016-01-01T00:00:00Z</release><publication>2016 Aug</publication><modification>2025-06-01T12:02:49.123Z</modification><creation>2025-06-01T12:02:49.123Z</creation></dates><accession>S-EPMC5074238</accession><cross_references><pubmed>27135656</pubmed><doi>10.1002/pbc.26018</doi></cross_references></HashMap>